Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2680
Source ID: NCT06570980
Associated Drug: Sulfonylurease With Metformin, Dpp4 Inhibitors With Metformin
Title: Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin
Interventions: DRUG: sulfonylurease with metformin, DPP4 inhibitors with Metformin
Outcome Measures: Primary: HbA1c%, achievment of target HbA1 less than 7%, 2-5years | Secondary: Insulin therapy, requirement of insulin therapy, 2-5years|hospitalization, requirement of hospitalization, 2-5years|3rd line therapy, addition of any 3rd drug, 2-5years|nephropathy, development of nephropathy, 2-5years
Sponsor/Collaborators: Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 200
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2023-08-25
Completion Date: 2024-08-30
Results First Posted:
Last Update Posted: 2024-08-26
Locations: BSMMU, Dhaka, 1000, Bangladesh
URL: https://clinicaltrials.gov/show/NCT06570980